Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Jaguar Health's Enterprise Value is $48.47 Mil.
Jaguar Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 was $-35.09 Mil. Therefore, Jaguar Health's EV-to-EBIT ratio for today is -1.38.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Jaguar Health's Enterprise Value is $48.47 Mil.
Jaguar Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was $-32.91 Mil. Therefore, Jaguar Health's EV-to-EBITDA ratio for today is -1.47.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Jaguar Health's Enterprise Value is $48.47 Mil.
Jaguar Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 was $29.54 Mil. Therefore, Jaguar Health's EV-to-Revenue ratio for today is 1.64.
EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow. As of today, Jaguar Health's Enterprise Value is $48.47 Mil.
Jaguar Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $-7.54 Mil. Therefore, Jaguar Health's EV-to-FCF ratio for today is -6.43.
*** Please note that the current Enterprise Value is calculated using the current market capitalization and the most recently available financial data. If key financial fields—Long-Term Debt & Capital Lease Obligation and Short-Term Debt & Capital Lease Obligation—are recorded as null in the latest reporting period, our data vendor will default to using data from the prior period with valid entries.
Jaguar Health (NAS:JAGX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Jaguar Health's current Enterprise Value is $48.47 Mil.
Jaguar Health's EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-35.09 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Jaguar Health's current Enterprise Value is $48.47 Mil.
Jaguar Health's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-32.91 Mil.
Jaguar Health's current Enterprise Value is $48.47 Mil.
Jaguar Health's Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $29.54 Mil.
Jaguar Health's current Enterprise Value is $48.47 Mil.
Jaguar Health's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.54 Mil.
Jaguar Health's current Enterprise Value is $48.47 Mil.
Jaguar Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.54 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jaguar Health Enterprise Value Related Terms
Jaguar Health Enterprise Value Historical Data
* Premium members only.
The historical data trend for Jaguar Health's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JAGX vs MBRX, BCDA, GRTX: Enterprise Value Comparison
For the Biotechnology subindustry, Jaguar Health's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jaguar Health Enterprise Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Jaguar Health's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Jaguar Health's Enterprise Value falls into.
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Jaguar Health's Enterprise Value for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jaguar Health (JAGX) has a Enterprise Value of $48.47 Mil as of Jul. 03, 2026. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Jaguar Health and its competitors.
Is Jaguar Health's Enterprise Value too high?
Jaguar Health's current Enterprise Value is $48.47 Mil. Overall, Jaguar Health has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Jaguar Health's Enterprise Value compare to MBRX and BCDA?
Jaguar Health's Enterprise Value of $48.47 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Enterprise Value for a Biotechnology company?
A good Enterprise Value depends on the Biotechnology industry context. However, Enterprise Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Enterprise Value mean?
A high Enterprise Value can signal that a stock is expensive relative to its fundamentals. Enterprise value equals the sum of market cap, debt and preferred shares less cash and equivalents. View historical data on Jaguar Health and its competitors. Jaguar Health's current Enterprise Value is $48.47 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jaguar Health stock overvalued right now?
Jaguar Health (JAGX) has a current Enterprise Value of $48.47 Mil. The current Enterprise Value is $48.47 Mil. Jaguar Health's overall GF Score™ is 22/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Enterprise Value calculated?
Enterprise Value is calculated from a company's financial statements. For Jaguar Health (JAGX), the current Enterprise Value is $48.47 Mil as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
22GF Score
Get the complete analysis for JAGX
Enterprise Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JAGX has been successfully added to your 
